Recordati Industria Chimica e Farmaceutica SpA
OTC:RICFY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recordati Industria Chimica e Farmaceutica SpA
OTC:RICFY
|
IT |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
Rio Tinto Ltd
F:CRA1
|
AU |
|
K
|
Kellogg Co
F:KEL
|
US |
|
G
|
Galderma Group AG
SIX:GALD
|
CH |
Intrinsic Value
Is RICFY undervalued or overvalued?
See the intrinsic value estimate for 
Recordati Industria Chimica e Farmaceutica SpA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Recordati Industria Chimica e Farmaceutica SpA Does
Recordati Industria Chimica e Farmaceutica is an Italian pharmaceutical company that develops, manufactures, and sells branded medicines. Its portfolio includes prescription drugs for specialty and rare conditions, along with some consumer healthcare products. It does not mainly sell generic bulk medicine; instead, it focuses on specific treatments where doctors, pharmacies, and hospitals need reliable branded products.
- Headquarters
- Italy IT
- Employees
- 4 654
- IPO date
- Jan 1, 1984
Recordati Industria Chimica e Farmaceutica has no economic moat
A Recordati medicine does not become more useful simply because more people take it, and the company’s size and broad reach do not keep rivals out. Across its specialty-care and rare-disease markets, competing medicines and generics can attract prescriptions, leaving no lasting company-wide barrier to protect customers and profits.
Read the full moat analysis
Revenue & Expenses Breakdown
Recordati Industria Chimica e Farmaceutica SpA
Earnings Waterfall
Recordati Industria Chimica e Farmaceutica SpA
The intrinsic value for Recordati Industria Chimica e Farmaceutica SpA (RICFY) under the Base Case is hidden USD.
Compared with the current market price of 12.47 USD, the stock appears hidden.